Top News

American Apparel Got Indication of Interest for $1.30-$1.40 per Share
Tweet TWEET

Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014

  Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on
                              February 13, 2014

Conference Call and Webcast to Follow

PR Newswire

WASHINGTON, Jan. 23, 2014

WASHINGTON, Jan. 23, 2014 /PRNewswire/ --Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA), a biopharmaceutical company focused on the development and
commercialization of products for the treatment of central nervous system
disorders, today announced it will release results for the fourth quarter of
2013 on Thursday, February 13, 2014, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, February
13, 2014, during which Vanda management will discuss the fourth quarter and
full year 2013 financial results and other corporate activities. To
participate in the conference call, please dial 1-888-895-5271 (domestic) or
1-847-619-6547 (international) and use passcode 36518617.

The conference call will be broadcast simultaneously and archived on the
Company's website, www.vandapharma.com.Investors should go to the website at
least 15 minutes early to register, download, and install any necessary audio
software.

A replay of the call will be available on Thursday, February 13, 2014,
beginning at 12:30 PM ET and will be accessible until Thursday, February 20,
2014, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for
domestic callers and 1-630-652-3042 for international callers. The passcode
number is 36518617.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of products for the treatment of central
nervous system disorders. For more on Vanda Pharmaceuticals Inc., please
visit www.vandapharma.com. 

Investor Contact:
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@troutgroup.com





SOURCE Vanda Pharmaceuticals Inc.

Website: http://www.vandapharma.com
 
Press spacebar to pause and continue. Press esc to stop.